Hydrochloric Acid

Hydrochloric Acid

SCHEMBL21145541

CCCCCCCCCCCCCCC(C)(C)C(C)(N)[Si](OC)(OC)OC.Cl

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 5/20 0.36
FDPS P14324 2/20 0.35
DNM1 Q05193 3/20 0.32
SPHK2 Q9NRA0 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5560162 1.00 SMPD1 (0.36) SMPD1FDPSDNM1SPHK2LMNA
Hydrochloric Acid SCHEMBL9624164 0.82 SMPD1 (0.34) SMPD1FDPSDNM1
Hydrochloric Acid SCHEMBL2142104 0.82 SMPD1 (0.34) SMPD1FDPSDNM1
SCHEMBL28560772 0.76 SMPD1 (0.40) SMPD1FDPSDNM1SPHK2LMNA
Hydrochloric Acid SCHEMBL25305152 0.76 SMPD1 (0.37) SMPD1FDPSDNM1SPHK2LMNA
Hydrochloric Acid SCHEMBL6389524 0.76 SMPD1 (0.37) SMPD1FDPSDNM1SPHK2LMNA
Hydrochloric Acid SCHEMBL537332 0.75 SMPD1 (0.38) SMPD1FDPSDNM1
Hydrochloric Acid SCHEMBL4033614 0.75 SMPD1 (0.38) SMPD1FDPSDNM1
SCHEMBL5912017 0.74 SMPD1 (0.40) SMPD1FDPSSPHK2LMNA
SCHEMBL2927935 0.74 TSHR (0.36) SMPD1FDPSLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737425-A1 COMPOSITIONS, KITS, METHODS AND USES FOR CLEANING, DISINFECTING, STERILIZING AND/OR TREATING Collidion, Inc. (US) 2020-11-18 EP claimed
US-20240196900-A1 Compositions, Kits, Methods and Uses for Cleaning, Disinfecting, Sterilizing and/or Treating Collidion, Inc. (US) 2024-06-20 US disclosed
US-11910797-B2 Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating Collidion, Inc. (US) 2024-02-27 US disclosed
CN-111801122-B Compositions, kits, methods and uses for cleaning, sanitizing, disinfecting and/or treating 科利迪恩公司 2023-06-02 CN disclosed
US-20220323626-A1 Compositions, Kits, Methods and Uses for Preventing Microbial Growth Collidion, Inc. (US) 2022-10-13 US disclosed
US-20220211044-A1 Compositions, Kits, Methods and Uses for Cleaning, Disinfecting, Sterilizing and/or Treating Collidion, Inc. (US) 2022-07-07 US disclosed
EP-3982735-A1 COMPOSITIONS, KITS, METHODS AND USES FOR PREVENTING MICROBIAL GROWTH Collidion, Inc. (US) 2022-04-20 EP disclosed
WO-2020252433-A1 COMPOSITIONS, KITS, METHODS AND USES FOR PREVENTING MICROBIAL GROWTH Collidion, Inc. (US) 2020-12-17 WO disclosed
EP-3737425-A1 COMPOSITIONS, KITS, METHODS AND USES FOR CLEANING, DISINFECTING, STERILIZING AND/OR TREATING Collidion, Inc. (US) 2020-11-18 EP disclosed
US-20190216090-A1 Compositions, Kits, Methods and Uses for Cleaning, Disinfecting, Sterilizing and/or Treating Collidion, Inc. (US) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240196900-A1 Compositions, Kits, Methods and Uses for Cleaning, Disinfecting, Sterilizing and/or Treating CAT, C9, GUCY1B2 SMPD1 299/4885FDPS 4859/4885DNM1 3862/4885
US-20220323626-A1 Compositions, Kits, Methods and Uses for Preventing Microbial Growth SPOUT1, GDA, SOD1 SMPD1 415/4885FDPS 4094/4885DNM1 4123/4885
US-20220211044-A1 Compositions, Kits, Methods and Uses for Cleaning, Disinfecting, Sterilizing and/or Treating CAT, C9, GUCY1B2 SMPD1 299/4885FDPS 4859/4885DNM1 3862/4885
US-11910797-B2 Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating CAT, C9, GUCY1B2 SMPD1 299/4885FDPS 4859/4885DNM1 3862/4885
US-20190216090-A1 Compositions, Kits, Methods and Uses for Cleaning, Disinfecting, Sterilizing and/or Treating CAT, C9, GUCY1B2 SMPD1 299/4885FDPS 4859/4885DNM1 3862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.